Prevention of cerebral vasospasm following aneurysmal subarachnoid hemorrhage using cilostazol administration with combination enteral and parental nutrition therapy - randomized open-labeled multi-institutional prospective study

Prevention of cerebral vasospasm following aneurysmal subarachnoid hemorrhage using cilostazol administration with combination enteral and parental nutrition therapy - randomized open-labeled multi-institutional prospective study - Prevention of cerebral vasospasm following aneurysmal subarachnoid hemorrhage using cilostazol administration with combination enteral and parental nutrition therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031246

Enrollment

120

Registered

2018-02-10

Start date

2018-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aneurysmal subarachnoid hemorrhage

Interventions

cilostazol administration combination enteral and parental nutrition therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. WFNS grade: I-IV 2. No new hemorrhage or infarction on computed tomography images one day after surgical intervention 3. No allergy or adverse effect for cilostazol 4. Written informed consent for attending this study

Exclusion criteria

Exclusion criteria: 1.WFNS grade: V 2. New hemorrhage or infarction on computed tomography images one day after surgical intervention 3. Allergy or adverse effect for cilostazol 4. No contraindication of cilostazol according to package medical insert

Design outcomes

Primary

Measure	Time frame
modified Rankin scale 0-2 at discharge	—

Countries

Japan

Contacts

Public ContactHidehito Kimura

Kobe University Hospital Neurosurgery

hkimura@med.kobe-u.ac.jp078-382-5966

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026